Gastrointestinal Pathogen Testing Market Size to be Worth USD 5.2 billion by 2031, with Notable CAGR of 3.2%| Transparency Market Research, Inc.
January 02, 2024 09:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The gastrointestinal pathogen testing industry was worth US$ 4.0 billion in 2022. A CAGR of...
Global In Vitro Diagnostics Market Demand will Reach a Value of US$ 115.43 Billion by the year 2028, at a CAGR of 6.3% | Data Analysis by Transparency Market Research
April 07, 2023 10:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 07, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – According to research, the global in vitro diagnostics market was worth US$ 70.51 Bn in...
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
January 13, 2023 13:07 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
Global Point-of-Care (POC) Blood Diagnostics Market is set to witness a growth rate of 6% by 2026 – Increasing Occurrence of Cardiovascular & Infectious Diseases
August 16, 2022 09:30 ET
|
Medi-Tech Insights
BRUSSELS, BELGIUM, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Description: Point-of-care (POC) testing entails performing a diagnostic test outside of a laboratory, or near a patient and at the site where...
Global Coagulation Testing Market Anticipated to Garner a Revenue of $3,566.0 Million at a CAGR of 5.9% during the Forecast Period, 2019-2026 - Absolute Report [Pages-105] by Research Dive
June 15, 2021 09:15 ET
|
Research Dive
New York, USA, June 15, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global coagulation testing market is projected to register a revenue of $3,566.0 million at a...
Patient Registry Software Market Size to Reach USD 2.96 Bn by 2027 | Rising Incidence of Chronic Diseases and Increasing Initiatives Related to Value-Based Care will be the Key Factor Driving the Industry Growth, States Emergen Research
January 26, 2021 14:00 ET
|
Emergen Research
Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of...
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
December 01, 2020 07:31 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., Dec. 01, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has...
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
June 12, 2020 08:00 ET
|
Cue Health Inc.
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and...
Sense Appoints John Bishop to its Board of Directors
April 21, 2020 02:00 ET
|
Sense Biodetection
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE...
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
March 23, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...